3,3',5-triiodothyroacetic acid has been researched along with Benign Neoplasms in 1 studies
tiratricol : A monocarboxylic acid that is (4-hydroxy-3,5-diiodophenyl)acetic acid in which the phenolic hydroxy group has been replaced by a 4-hydroxy-3-iodophenoxy group. It is a thyroid hormone analogue that has been used in the treatment of thyroid hormone resistance syndrome.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Actis, M | 1 |
| Inoue, A | 1 |
| Evison, B | 1 |
| Perry, S | 1 |
| Punchihewa, C | 1 |
| Fujii, N | 1 |
1 other study available for 3,3',5-triiodothyroacetic acid and Benign Neoplasms
| Article | Year |
|---|---|
Small molecule inhibitors of PCNA/PIP-box interaction suppress translesion DNA synthesis.
Topics: Amino Acid Sequence; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cisplatin; DNA; DN | 2013 |